Protagonist Therapeutics (PTGX) Interest Coverage Ratio (QoQ) (2016 - 2024)
Protagonist Therapeutics (PTGX) Interest Coverage Ratio (QoQ) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 797.87% |
| Sep 30, 2024 | -15.32% |
| Jun 30, 2024 | -106.32% |
| Mar 31, 2024 | 2,218.12% |
| Dec 31, 2023 | 74.70% |
| Sep 30, 2023 | -11,939.18% |
| Jun 30, 2023 | 19.27% |
| Mar 31, 2023 | 98.95% |
| Dec 31, 2022 | -285.18% |
| Sep 30, 2022 | 42.39% |
| Jun 30, 2022 | -5,211.92% |
| Mar 31, 2022 | 99.31% |
| Dec 31, 2021 | -5,316.16% |
| Sep 30, 2021 | -588.99% |
| Jun 30, 2021 | 50.76% |
| Mar 31, 2021 | -101.64% |
| Dec 31, 2020 | 11,133.41% |
| Sep 30, 2020 | 63.93% |
| Jun 30, 2020 | 98.66% |
| Mar 31, 2020 | -395.99% |